- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Neuraxis Inc (NRXS)
Track the Neuraxis share price today and view real-time NRXS share price data, including charts, technicals, and key financials. View the NRXS premarket stock price ahead of the market session or assess the after hours quote. Explore NRXS stock price movements, trading volume, and market activity across the NYSE exchange.
What Is the Neuraxis Stock Price Today?
The Neuraxis stock price today is 5.750.
What Is the Stock Symbol for Neuraxis?
The stock symbol for Neuraxis is ""NRXS.""
What Stock Exchange Does Neuraxis Trade On?
Neuraxis is listed and trades on the NYSE stock exchange.
Is Neuraxis a Good Stock to Buy?
Determining whether Neuraxis or any stock is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the NRXS quote. (ISIN: US64134X2018)
What Is the Neuraxis Stock Price Today?
The Neuraxis stock price today is 5.750.
What Is the Stock Symbol for Neuraxis?
The stock symbol for Neuraxis is ""NRXS.""
What Stock Exchange Does Neuraxis Trade On?
Neuraxis is listed and trades on the NYSE stock exchange.
Is Neuraxis a Good Stock to Buy?
Determining whether Neuraxis or any stock is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the NRXS quote. (ISIN: US64134X2018)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
5.730
6.220
52 wk Range
2.210
9.330
NRXS is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
5.7306.220
52 wk Range
2.2109.330
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
NRXS Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
11.000
Upside
+91.30%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts do not anticipate the company will be profitable this year
Form 4 Neuraxis Inc For: 8 October- Investing.com
- Form 4 Neuraxis Inc For: 8 October
- Investing.com
Neuraxis CRO Carrico buys $1,587 in common stock- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Analyst Ratings
2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 11.000
(+91.30% Upside)
Neuraxis Inc Earnings Call Summary for Q3/2026
- NeurAxis Q3 revenue surged 150% YoY to $2M; gross margin expanded to 86.6% from 83.3%, marking ninth consecutive quarter of double-digit growth.
- Payer coverage expanded to 147M lives after adding two major insurers; prior authorization approval rates jumped to 38% from 12% through 2025.
- Company posted $6.5M net loss vs. $2.1M YoY; ended quarter with $4.5M cash, raising additional $1.7M post-quarter through ATM facility.
- Management expects meaningful revenue benefits from new payer wins in 2027; plans to expand to 10-11 direct sales reps and five new territories by year-end.
- Medicaid expansion targeted for 90% of states by spring 2027; 300+ patient trial in adult functional dyspepsia enrollment to begin soon.
Last Updated: 10/11/2026, 01:54 am
Read Full TranscriptEarnings
Latest Release
09/11/2026
EPS / Forecast
-0.21 / -0.12
Revenue / Forecast
2.03M / --
Compare NRXS to Peers and Sector
Metrics to compare | NRXS | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipNRXSPeersSector | |
|---|---|---|---|---|
P/E Ratio | −5.6x | −5.1x | −0.2x | |
PEG Ratio | 0.64 | −0.22 | 0.00 | |
Price/Book | 20.0x | 5.6x | 2.6x | |
Price / LTM Sales | 11.1x | 3.8x | 2.8x | |
Upside (Analyst Target) | 89.0% | 176.3% | 60.5% | |
Fair Value Upside | Unlock | 10.3% | 7.8% | Unlock |
NeurAxis, Inc., a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 8 years of age with functional abdominal pain associated with irritable bowel syndrome (IBS), functional dyspepsia (FD) and associated FD nausea symptoms. The company also offers rectal expulsion device, a screening tool that helps to detects evacuation disorders. It sells its products to healthcare companies, such as hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022. NeurAxis, Inc. was founded in 2011 and is headquartered in Carmel, Indiana.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Neuraxis (NRXS) Stock Price Today?
The Neuraxis stock price today is 5.750 USD.
What Stock Exchange Does Neuraxis Trade On?
Neuraxis is listed and trades on the New York Stock Exchange.
What Is the Stock Symbol for Neuraxis?
The stock symbol for Neuraxis is "NRXS."
What Is the Neuraxis Market Cap?
As of today, Neuraxis market cap is 75.720M USD.
What Is Neuraxis's Earnings Per Share (TTM)?
The Neuraxis EPS (TTM) is -1.10.
From a Technical Analysis Perspective, Is NRXS a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Neuraxis Stock Split?
Neuraxis has split 0 times.
How Many Employees Does Neuraxis Have?
Neuraxis has 24 employees.
What is the current trading status of Neuraxis (NRXS)?
As of 12/11/2026, Neuraxis (NRXS) is trading at a price of 5.750 USD, with a previous close of 6.030 USD. The stock has fluctuated within a day range of 5.730 USD to 6.220 USD, while its 52-week range spans from 2.210 USD to 9.330 USD.
What Is Neuraxis (NRXS) Price Target According to Analysts?
The average 12-month price target for Neuraxis is 11.000 USD, with a high estimate of 13 USD and a low estimate of 9 USD. 2 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +91.30% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.